Omada Health, Inc. (NASDAQ:OMDA – Get Free Report) CFO Steven Cook sold 1,108 shares of the company’s stock in a transaction on Thursday, August 27th. The shares were sold at an average price of $25.00, for a total value of $27,700.00. Following the completion of the sale, the chief financial officer owned 187,209 shares in the company, valued at $4,680,225. This trade represents a 0.59% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
Omada Health Stock Performance
Shares of NASDAQ OMDA opened at $24.55 on Tuesday. Omada Health, Inc. has a 52-week low of $10.28 and a 52-week high of $26.92. The business has a fifty day moving average of $22.41 and a two-hundred day moving average of $17.29. The stock has a market cap of $1.50 billion, a PE ratio of 491.00 and a beta of 1.73.
Omada Health (NASDAQ:OMDA – Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported $0.08 earnings per share for the quarter, topping the consensus estimate of ($0.02) by $0.10. Omada Health had a net margin of 1.39% and a return on equity of 2.60%. The business had revenue of $87.83 million for the quarter, compared to analyst estimates of $80.93 million. Analysts predict that Omada Health, Inc. will post 0.09 earnings per share for the current year.
Wall Street Analyst Weigh In
A number of research analysts have recently issued reports on the stock. Citizens Jmp lifted their target price on shares of Omada Health from $27.00 to $32.00 and gave the company a “market outperform” rating in a research note on Friday, August 14th. The Goldman Sachs Group restated a “buy” rating on shares of Omada Health in a research report on Friday, May 8th. Weiss Ratings upgraded Omada Health from a “sell (e+)” rating to a “sell (d+)” rating in a research report on Tuesday, August 11th. Barclays boosted their price objective on Omada Health from $20.00 to $25.00 and gave the stock an “overweight” rating in a research note on Monday, August 3rd. Finally, Robert W. Baird increased their target price on Omada Health from $15.00 to $25.00 and gave the stock a “neutral” rating in a report on Wednesday, August 12th. Eleven equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $26.50.
Check Out Our Latest Stock Report on OMDA
Hedge Funds Weigh In On Omada Health
Large investors have recently modified their holdings of the stock. Corient Private Wealth LP grew its stake in shares of Omada Health by 252.5% during the second quarter. Corient Private Wealth LP now owns 145,118 shares of the company’s stock valued at $3,185,000 after purchasing an additional 103,955 shares during the last quarter. California State Teachers Retirement System lifted its holdings in Omada Health by 465.1% during the 2nd quarter. California State Teachers Retirement System now owns 10,229 shares of the company’s stock worth $225,000 after buying an additional 8,419 shares in the last quarter. Round Rock Advisors LLC acquired a new position in Omada Health during the 2nd quarter worth $745,000. Susquehanna Fundamental Investments LLC bought a new position in Omada Health in the 2nd quarter valued at $503,000. Finally, Hsbc Holdings PLC bought a new position in Omada Health in the 2nd quarter valued at $435,000.
Omada Health Company Profile
Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.
In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.
Recommended Stories
- Five stocks we like better than Omada Health
- Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
- Insiders Are Betting Big on These 3 Healthcare Stocks
- 3 Stocks for Investors Who Still Believe Cash Is King
- Dollar General and Dollar Tree Are Recovering, But Not for the Same Reason
Receive News & Ratings for Omada Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omada Health and related companies with MarketBeat.com's FREE daily email newsletter.
